Get to know the newest members of PGSG!
Dr. Lori Chibnik
Dr. Lori Chibnik, PhD, MPH, is the newest PGSG faculty member. She is an Assistant Professor of Neurology at HMS and Brigham and Women’s Hospital, with a secondary appointment in HSPH-Epidemiology. Her research focuses on genetics and epigenetics of Alzheimer’s disease, cognitive decline, and multiple sclerosis; and longitudinal data analysis and risk prediction. She and Peter Kraft co-teach EPI 215: Advanced Topics in Case-Control & Cohort Studies (aka “Big data for Epidemiologists”) in the Fall semester. Dr. Chibnik also developed and leads an interactive biostatistics course at the KwaZulu-Natal Research Institute for Tuberculosis and HIV in Durban, South Africa.
Xuanyao obtained her Ph.D. from National University of Singapore and joined the Price Lab in December 2014. She worked on population genetics and developed statistical methods for detecting positive natural selection signals in both human and parasite genome. Her current research focuses on partitioning heritability across functional categories and inferring genetic component of population differences in phenotypes.
Dr. Wonil Chung received his Ph.D. in Biostatistics from the University of North Carolina at Chapel Hill (UNC-CH) and joined the Liang lab as a Postdoctoral Fellow in June 2014. His research mainly focuses on the development of statistical methodologies for genome-wide association studies (GWAS) on complex human diseases and implementation of efficient software for application to large scale genomic and epigenomic data. He will work on the statistical analysis of large genetic data and actively participate in many projects during his years at HSPH.
Visiting Research Fellow
Dr. Ga Liao is a Visiting Research Fellow from the West China School of Stomatology, Sichuan University, P.R. China. During his year in Boston, he will be working with Dr. Liming Liang in the Epidemiology Department at HSPH. Dr. Liao’s work explores the susceptibility variants and genes related to oral diseases, especially for head and neck cancers via whole genome sequencing and GWAS data. He will also study the underlying mechanisms of these causative genes.